Target intelligence / Profile preview

Beta-ketoacyl-(acyl carrier protein) synthase III (PqsBC) (PqsBC)

Target
PqsBC
Molecular classification
Enzyme, Transferase, Beta-ketoacyl-acyl carrier protein synthase
01

Overview

PqsBC is a heterodimeric enzyme complex in the opportunistic pathogen Pseudomonas aeruginosa, composed of the PqsB and PqsC subunits [1, 3]. It belongs to the beta-ketoacyl-acyl carrier protein synthase III (FabH) family and is specifically responsible for the condensation of 2-aminobenzoylacetate (2-ABA) with octanoyl-CoA to produce 2-heptyl-4-quinolone (HHQ) [1, 2]. HHQ serves as the immediate precursor to the Pseudomonas quinolone signal (PQS), a critical autoinducer in one of the primary quorum-sensing systems used by the bacterium to regulate virulence factors such as pyocyanin, elastase, and biofilm formation [2, 5]. Due to its central role in the alkylquinolone biosynthetic pathway, PqsBC has emerged as a prominent target for anti-virulence drug development aimed at disrupting bacterial communication rather than killing the pathogen [3, 4]. Inhibiting PqsBC effectively attenuates the pathogen's ability to coordinate damage and evade the host immune system, which is of significant interest for treating chronic lung infections in cystic fibrosis patients [4, 5]. Experimental inhibitors, including the natural competitive inhibitor 2-aminoacetophenone and various synthetic benzamide-benzimidazole derivatives, have demonstrated the potential to block HHQ production and reduce virulence factor expression [1, 4].

Other names
PqsB/PqsC complex2-heptyl-4-quinolone synthaseAlkylquinolone biosynthesis enzymePqsB/C heterodimerHHQ synthase
02

Mechanism of action

Inhibits the condensation of 2-aminobenzoylacetate and octanoyl-CoA, thereby blocking the synthesis of the quorum-sensing signal 2-heptyl-4-quinolone (HHQ).

03

Biological functions

Signal transductionQuorum sensingAlkylquinolone biosynthesisVirulence factor regulationBiofilm formation
04

Disease associations

InfectionCystic fibrosisBacterial pneumoniaWound infection
05

Safety considerations

Potential for bacterial resistance development via alternate signaling pathwaysChallenges in achieving host-pathogen specificity to avoid interfering with human metabolic enzymesAdaptation of the quorum-sensing network through bypass mechanisms
06

Interacting drugs

2-aminoacetophenone

3 more in the full profile.

07

Biomarkers

2-heptyl-4-quinolone (HHQ)Pseudomonas quinolone signal (PQS)Pyocyanin production

Beyond the preview

Go deeper on Beta-ketoacyl-(acyl carrier protein) synthase III (PqsBC) (PqsBC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-ketoacyl-(acyl carrier protein) synthase III (PqsBC) (PqsBC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call